Malina, Shenalou P.

HRN: 23-03-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2023
CEFTRIAXONE 1G (VIAL)
05/11/2023
05/18/2023
IV
1g
Q12
Typhoid Fever
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: